Strand Therapeutics

Cambridge, MA

Strand Therapeutics is a developer of a biotechnology platform intended to create gene therapies powered by synthetic biology.The company's offerings include immunotherapies to help cells produce target cancer-killing proteins during immunotherapy, enabling patients to improve their body's immune system to fight cancer.

Company Details

Founded: 2017
Employees: Between 50 - 200 employees
Raised: $104,200,000
Headquarters Location: Cambridge, MA
Public: No
Acquired: No
CEO: Jacob Becraft
Founders: Tasuku Kitada
Jacob Becraft
Darrell Irvine
Ron Weiss

Company Collections

These are collections Strand Therapeutics is a part of. Click on the collection name to view similar companies.

Strand Therapeutics' Industries

Medical Organizations

Health Care Companies

Biotechnology Companies

Strand Therapeutics' Tech Stack